Cardiovascular risk assessment in metabolic syndrome: view from PROCAM

被引:18
|
作者
Assmann, G
Nofer, JR
Schulte, H
机构
[1] Univ Munster, Inst Klin Chem, D-48129 Munster, Germany
[2] Univ Munster, Lab Med, D-48129 Munster, Germany
[3] Univ Munster, Inst Arterioskleroseforsch, D-4400 Munster, Germany
关键词
D O I
10.1016/j.ecl.2004.03.017
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The near-epidemic proportions of diabetes mellitus and the metabolic syndrome over the past years are widely ascribed to a changing socioeconomic environment that contributes to excessive nutritional intake and sedentary lifestyle. Paradoxically, this gives room for expectations, because timely lifestyle and dietary intervention could decelerate the progression of diabetes, reduce the rate of development of cardiovascular complications, and reduce costs associated with treatment and rehabilitation. This approach, however, depends on the development of tools that allow precise estimation of risk of cardiovascular complications before the onset of diabetes mellitus and the risk of developing type 2 diabetes itself. This article reviews the progress that has been made toward reaching these goals based on the results of the PROspective Cardiovascular Munster (PROCAM) study.
引用
收藏
页码:377 / +
页数:17
相关论文
共 50 条
  • [41] Metabolic syndrome and cardiovascular risk among adults
    Hunain, Reem
    Reddy, Sravan Kumar T.
    Hande, H. Manjunath
    Shivashankar, K. N.
    Saravu, Kavitha
    Mallya, Sneha Deepak
    [J]. INDIAN JOURNAL OF COMMUNITY HEALTH, 2018, 30 (01) : 38 - 44
  • [42] Sympathetic Overdrive and Cardiovascular Risk in the Metabolic Syndrome
    Guido Grassi
    [J]. Hypertension Research, 2006, 29 : 839 - 847
  • [43] Metabolic syndrome - cardiovascular disease risk and more
    Carulli, N
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2005, 22 : 1 - 2
  • [44] Inflammatory markers and cardiovascular risk in the metabolic syndrome
    Espinola-Klein, Christine
    Gori, Tommaso
    Blankenberg, Stefan
    Munzel, Thomas
    [J]. FRONTIERS IN BIOSCIENCE-LANDMARK, 2011, 16 : 1663 - 1674
  • [45] Pharmacological approach to cardiovascular risk in metabolic syndrome
    Bellis, Alessandro
    Trimarco, Bruno
    [J]. JOURNAL OF CARDIOVASCULAR MEDICINE, 2013, 14 (06) : 403 - 409
  • [46] Cardiovascular risk: Prevention and treatment of the metabolic syndrome
    Tuomilehto, J
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2005, 68 : S28 - S35
  • [47] INFLUENCE OF METABOLIC SYNDROME PROFILE ON CARDIOVASCULAR RISK
    Mitu, F.
    Cobzaru, Roxana
    Leon, Maria-Magdalena
    [J]. MEDICAL-SURGICAL JOURNAL-REVISTA MEDICO-CHIRURGICALA, 2013, 117 (02): : 308 - 314
  • [48] Cardiovascular risk in the metabolic syndrome: Fact or fiction?
    Nilsson P.M.
    [J]. Current Cardiology Reports, 2007, 9 (6) : 479 - 485
  • [49] Metabolic and cardiovascular risk factors in Klinefelter syndrome
    Spaziani, Matteo
    Radicioni, Antonio F.
    [J]. AMERICAN JOURNAL OF MEDICAL GENETICS PART C-SEMINARS IN MEDICAL GENETICS, 2020, 184 (02) : 334 - 343
  • [50] Erectile dysfunction, metabolic syndrome and cardiovascular risk
    Baldo, Omer
    Eardley, Ian
    Summers, Lucinda K.
    [J]. DIABETES, 2007, 56 : A594 - A595